关注
Mir S Adil
Mir S Adil
Postdoctoral Scholar at Stanford University
在 stanford.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Cell-cell junctions: structure and regulation in physiology and pathology
MS Adil, SP Narayanan, PR Somanath
Tissue Barriers, 2020
802020
The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis
A Alwhaibi, A Verma, MS Adil, PR Somanath
Pharmacological research 145, 104270, 2019
642019
Targeting Akt-associated microRNAs for cancer therapeutics
MS Adil, D Khulood, PR Somanath
Biochemical Pharmacology, 2020
282020
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells
S Artham, A Verma, A Alwhaibi, MS Adil, S Manicassamy, DH Munn, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 318 (4 …, 2020
232020
PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling
A Verma, S Artham, A Alwhaibi, MS Adil, BS Cummings, PR Somanath
Biochemical pharmacology 177, 113943, 2020
212020
EMPADE study: Evaluation of medical prescriptions and adverse drug events in COPD patients admitted to intensive care unit
MS Adil, MA Khan, MN Khan, I Sultan, MA Khan, SA Ali, A Farooqui
Journal of Clinical and Diagnostic Research: JCDR 9 (11), FC05, 2015
212015
Endothelial permeability assays in vitro
MS Adil, PR Somanath
Permeability Barrier: Methods and Protocols, 177-191, 2021
192021
Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care Hospital
A Khan, MS Adil, K Nematullah, S Ihtisham, K Aamer, S Aamir
Journal of basic and clinical pharmacy 6 (3), 84, 2015
192015
Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis
A Alwhaibi, A Verma, S Artham, MS Adil, PR Somanath
Biochemical pharmacology 168, 1-13, 2019
152019
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?
MS Adil, SP Narayanan, PR Somanath
Drug discoveries & therapeutics 14 (5), 256-258, 2020
122020
Vascular permeability assays in vivo
MS Adil, PR Somanath
Permeability Barrier: Methods and Protocols, 165-175, 2021
92021
A questionnaire study of food–drug interactions to assess knowledge of people from diverse backgrounds
SA Sajid, R Sultana, M Masaratunnisa, S Naaz, MS Adil
Asian J. Med. Health 5, 1-9, 2017
82017
Convalescent plasma appears efficacious and safe in COVID-19
D Khulood, MS Adil, R Sultana, Nimra
Therapeutic Advances in Infectious Disease 7, 2049936120957931, 2020
72020
PRIME study: Prescription review to impede medication errors
MS Adil, R Sultana, D Khulood
International Journal of Risk & Safety in Medicine 31 (2), 67-79, 2020
72020
Anti-Tuberculosis Drug-Induced Hepatitis–A Case Report
K Amer, SA Aamir, K Nematullah, S Ihtisham, M Maazuddin
Indian Journal of Pharmacy Practice 6 (2), 2013
72013
Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection
MS Adil, D Khulood, SP Narayanan, PR Somanath
Tissue Barriers 10 (3), 2000300, 2022
62022
Akt‐independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS‐CoV2 infection
MS Adil, A Verma, M Rudraraju, SP Narayanan, PR Somanath
Journal of cellular physiology 236 (9), 6597-6606, 2021
62021
Cisatracurium attenuates LPS-induced modulation of MMP3 and junctional protein expression in human microvascular endothelial cells
RW Kadry, MS Adil, AS Newsome, PR Somanath
Bioscience trends 15 (1), 50-54, 2021
62021
Distinct effects of pharmacological inhibition of stromelysin1 on endothelial‐to‐mesenchymal transition and myofibroblast differentiation
A Alharthi, A Verma, H Sabbineni, MS Adil, PR Somanath
Journal of Cellular Physiology, 2020
62020
Drug dosing in obese patients: a dilemma
A Kaul, MS Adil
Int J Adv Pharm 3 (6), 59-65, 2014
62014
系统目前无法执行此操作,请稍后再试。
文章 1–20